Comparative Fitness of a Parent Leishmania donovani Clinical Isolate and Its Experimentally Derived Paromomycin-Resistant Strain.
Paromomycin has recently been introduced for the treatment of visceral leishmaniasis and emergence of drug resistance can only be appropriately judged upon its long term routine use in the field. Understanding alterations in parasite behavior linked to paromomycin-resistance may be essential to asse...
Main Authors: | Sarah Hendrickx, Annelies Leemans, Annelies Mondelaers, Suman Rijal, Basudha Khanal, Jean-Claude Dujardin, Peter Delputte, Paul Cos, Louis Maes |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2015-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4607421?pdf=render |
Similar Items
-
Experimental induction of paromomycin resistance in antimony-resistant strains of L. donovani: outcome dependent on in vitro selection protocol.
by: Sarah Hendrickx, et al.
Published: (2012-01-01) -
Combined treatment of miltefosine and paromomycin delays the onset of experimental drug resistance in Leishmania infantum.
by: Sarah Hendrickx, et al.
Published: (2017-05-01) -
Transcriptome profiling identifies genes/pathways associated with experimental resistance to paromomycin in Leishmania donovani
by: Aditya Verma, et al.
Published: (2017-12-01) -
Phenotypic adaptations of Leishmania donovani to recurrent miltefosine exposure and impact on sand fly infection
by: Sarah Hendrickx, et al.
Published: (2020-02-01) -
Linking in vitro and in vivo survival of clinical Leishmania donovani strains.
by: Manu Vanaerschot, et al.
Published: (2010-01-01)